{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:42:56Z","timestamp":1792176176226,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10072-021-05664-7","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T04:02:42Z","timestamp":1635220962000},"page":"153-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4937-2158","authenticated-orcid":false,"given":"Oliver","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Mahjoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nily","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Marie","family":"Surmava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saber","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Marissa","family":"Lagman-Bartolome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"issue":"1","key":"5664_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/17425255.2018.1416097","volume":"14","author":"A Gonz\u00e1lez-Hern\u00e1ndez","year":"2018","unstructured":"Gonz\u00e1lez-Hern\u00e1ndez A, Marichal-Cancino BA, MaassenVanDenBrink A, Villal\u00f3n CM (2018) Side effects associated with current and prospective antimigraine pharmacotherapies, (in eng). Expert Opin Drug Metab Toxicol 14(1):25\u201341. https:\/\/doi.org\/10.1080\/17425255.2018.1416097","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"5664_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/14740338.2017.1338272","volume":"16","author":"S Tacconelli","year":"2017","unstructured":"Tacconelli S, Bruno A, Grande R, Ballerini P, Patrignani P (2017) Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts, (in eng). Expert Opin Drug Saf 16(7):791\u2013807. https:\/\/doi.org\/10.1080\/14740338.2017.1338272","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"5664_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/0333102414550416","volume":"35","author":"G Roberto","year":"2015","unstructured":"Roberto G et al (2015) Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies, (in eng). Cephalalgia 35(2):118\u2013131. https:\/\/doi.org\/10.1177\/0333102414550416","journal-title":"Cephalalgia"},{"key":"5664_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/jpr.s132833","volume":"11","author":"A Negro","year":"2018","unstructured":"Negro A, Koverech A, Martelletti P (2018) Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential, (in eng). J Pain Res 11:515\u2013526. https:\/\/doi.org\/10.2147\/jpr.s132833","journal-title":"J Pain Res"},{"issue":"10","key":"5664_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrneurol.2016.124","volume":"12","author":"HC Diener","year":"2016","unstructured":"Diener HC, Holle D, Solbach K, Gaul C (2016) Medication-overuse headache: risk factors, pathophysiology and management, (in eng). Nat Rev Neurol 12(10):575\u2013583. https:\/\/doi.org\/10.1038\/nrneurol.2016.124","journal-title":"Nat Rev Neurol"},{"key":"5664_CR6","doi-asserted-by":"publisher","unstructured":"Burch R, Rayhill M (2018) New preventive treatments for migraine,\" (in eng), Bmj 361 k2507. https:\/\/doi.org\/10.1136\/bmj.k2507","DOI":"10.1136\/bmj.k2507"},{"issue":"3","key":"5664_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11916-017-0608-x","volume":"21","author":"S Miller","year":"2017","unstructured":"Miller S, Matharu M (2017) Non-invasive neuromodulation in primary headaches, (in eng). Curr Pain Headache Rep 21(3):14. https:\/\/doi.org\/10.1007\/s11916-017-0608-x","journal-title":"Curr Pain Headache Rep"},{"issue":"8","key":"5664_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1526-4610.2011.01966.x","volume":"51","author":"B Jenkins","year":"2011","unstructured":"Jenkins B, Tepper SJ (2011) Neurostimulation for primary headache disorders, part 1: pathophysiology and anatomy, history of neuromodulation in headache treatment, and review of peripheral neuromodulation in primary headaches, (in eng). Headache 51(8):1254\u20131266. https:\/\/doi.org\/10.1111\/j.1526-4610.2011.01966.x","journal-title":"Headache"},{"issue":"Pt 7","key":"5664_CR9","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/brain\/aww118","volume":"139","author":"AP Andreou","year":"2016","unstructured":"Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ (2016) Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine, (in eng). Brain 139(Pt 7):2002\u20132014. https:\/\/doi.org\/10.1093\/brain\/aww118","journal-title":"Brain"},{"issue":"5","key":"5664_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.pain.2014.02.009","volume":"155","author":"ML Oshinsky","year":"2014","unstructured":"Oshinsky ML, Murphy AL, Hekierski H Jr, Cooper M, Simon BJ (2014) Noninvasive vagus nerve stimulation as treatment for trigeminal allodynia, (in eng). Pain 155(5):1037\u20131042. https:\/\/doi.org\/10.1016\/j.pain.2014.02.009","journal-title":"Pain"},{"issue":"4","key":"5664_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/j.pain.0000000000000437","volume":"157","author":"SP Chen","year":"2016","unstructured":"Chen SP et al (2016) Vagus nerve stimulation inhibits cortical spreading depression, (in eng). Pain 157(4):797\u2013805. https:\/\/doi.org\/10.1097\/j.pain.0000000000000437","journal-title":"Pain"},{"issue":"9","key":"5664_CR12","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/pme.12792","volume":"16","author":"TJ Schwedt","year":"2015","unstructured":"Schwedt TJ, Vargas B (2015) Neurostimulation for treatment of migraine and cluster headache, (in eng). Pain Med 16(9):1827\u20131834. https:\/\/doi.org\/10.1111\/pme.12792","journal-title":"Pain Med"},{"issue":"9","key":"5664_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11916-018-0716-2","volume":"22","author":"KW Grimsrud","year":"2018","unstructured":"Grimsrud KW, Halker Singh RB (2018) Emerging treatments in episodic migraine, (in eng). Curr Pain Headache Rep 22(9):61. https:\/\/doi.org\/10.1007\/s11916-018-0716-2","journal-title":"Curr Pain Headache Rep"},{"issue":"6","key":"5664_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.brs.2018.08.010","volume":"11","author":"J Redgrave","year":"2018","unstructured":"Redgrave J et al (2018) Safety and tolerability of transcutaneous vagus nerve stimulation in humans; a systematic review, (in eng). Brain Stimul 11(6):1225\u20131238. https:\/\/doi.org\/10.1016\/j.brs.2018.08.010","journal-title":"Brain Stimul"},{"issue":"7","key":"5664_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/jnnp-2018-320113","volume":"90","author":"U Reuter","year":"2019","unstructured":"Reuter U, McClure C, Liebler E, Pozo-Rosich P (2019) Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials, (in eng). J Neurol Neurosurg Psychiatry 90(7):796\u2013804. https:\/\/doi.org\/10.1136\/jnnp-2018-320113","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"5664_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/head.13479","volume":"59","author":"JM Stilling","year":"2019","unstructured":"Stilling JM, Monchi O, Amoozegar F, Debert CT (2019) Transcranial magnetic and direct current stimulation (TMS\/tDCS) for the treatment of headache: a systematic review, (in eng). Headache 59(3):339\u2013357. https:\/\/doi.org\/10.1111\/head.13479","journal-title":"Headache"},{"issue":"1","key":"5664_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s10194-017-0792-4","volume":"18","author":"L Lan","year":"2017","unstructured":"Lan L, Zhang X, Li X, Rong X, Peng Y (2017) The efficacy of transcranial magnetic stimulation on migraine: a meta-analysis of randomized controlled trails, (in eng). J Headache Pain 18(1):86. https:\/\/doi.org\/10.1186\/s10194-017-0792-4","journal-title":"J Headache Pain"},{"issue":"4","key":"5664_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/s1474-4422(10)70054-5","volume":"9","author":"RB Lipton","year":"2010","unstructured":"Lipton RB et al (2010) Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial, (in eng). Lancet Neurol 9(4):373\u2013380. https:\/\/doi.org\/10.1016\/s1474-4422(10)70054-5","journal-title":"Lancet Neurol"},{"key":"5664_CR19","doi-asserted-by":"publisher","unstructured":"Lai YH, Huang YC, Huang LT, Chen RM, Chen C (2020) Cervical noninvasive vagus nerve stimulation for migraine and cluster headache: a systematic review and Meta-Analysis, (in eng). Neuromodulation. https:\/\/doi.org\/10.1111\/ner.13122","DOI":"10.1111\/ner.13122"},{"key":"5664_CR20","doi-asserted-by":"publisher","unstructured":"Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, (in eng). Bmj 339 b2700. https:\/\/doi.org\/10.1136\/bmj.b2700","DOI":"10.1136\/bmj.b2700"},{"key":"5664_CR21","doi-asserted-by":"publisher","unstructured":"Diener HC et al (2019) Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition, (in eng). Cephalalgia 39(6) 687\u2013710. https:\/\/doi.org\/10.1177\/0333102419828967","DOI":"10.1177\/0333102419828967"},{"key":"5664_CR22","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition, (in eng). Cephalalgia 38(1) 1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"key":"5664_CR23","doi-asserted-by":"publisher","unstructured":"Tfelt-Hansen P et al (2012) Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators, (in eng). Cephalalgia 32(1) 6\u201338. https:\/\/doi.org\/10.1177\/0333102411417901","DOI":"10.1177\/0333102411417901"},{"issue":"1","key":"5664_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0333102418811573","volume":"39","author":"DE Chou","year":"2019","unstructured":"Chou DE, ShnaydermanYugrakh M, Winegarner D, Rowe V, Kuruvilla D, Schoenen J (2019) Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trial, (in eng). Cephalalgia 39(1):3\u201314. https:\/\/doi.org\/10.1177\/0333102418811573","journal-title":"Cephalalgia"},{"key":"5664_CR25","doi-asserted-by":"publisher","unstructured":"Martelletti P et al (2018) Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial, (in eng), J Headache Pain 19(1) 101. https:\/\/doi.org\/10.1186\/s10194-018-0929-0","DOI":"10.1186\/s10194-018-0929-0"},{"key":"5664_CR26","unstructured":"Kuruvilla D. A Phase III Trial of e-TNS for the Acute Treatment of Migraine (TEAM) [Online] Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03465904"},{"key":"5664_CR27","doi-asserted-by":"publisher","unstructured":"Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials, (in eng). Bmj 366 l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"5664_CR28","unstructured":"GradePro. GDT: GRADEpro Guideline Development Tool. Evidence Prime, Inc. gradepro.org (accessed)"},{"key":"5664_CR29","unstructured":"Review Manager (RevMan) (2014) The Cochrane Collaboration, Copenhagen: the Nordic Cochrane Centre"},{"key":"5664_CR30","doi-asserted-by":"crossref","unstructured":"Hering-Hanit R (2017) A prospective, randomized, single blind, parallel-group, placebo controlled clinical study to evaluate the short-term effectiveness of combined occipital and supraorbital transcutaneous nerve stimulation (OS-TNS) in treating migraine, in IHC Posters - Thursday and Friday. vol. 37, ed: Cephalalgia, p. 73","DOI":"10.1177\/0333102417719573"},{"issue":"13","key":"5664_CR31","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/wnl.0000000000003760","volume":"88","author":"D Yarnitsky","year":"2017","unstructured":"Yarnitsky D et al (2017) Nonpainful remote electrical stimulation alleviates episodic migraine pain, (in eng). Neurology 88(13):1250\u20131255. https:\/\/doi.org\/10.1212\/wnl.0000000000003760","journal-title":"Neurology"},{"issue":"8","key":"5664_CR32","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/head.13551","volume":"59","author":"D Yarnitsky","year":"2019","unstructured":"Yarnitsky D et al (2019) Remote Electrical Neuromodulation (REN) Relieves acute migraine: a randomized, double-blind, placebo-controlled, multicenter trial, (in eng). Headache 59(8):1240\u20131252. https:\/\/doi.org\/10.1111\/head.13551","journal-title":"Headache"},{"issue":"4","key":"5664_CR33","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1212\/wnl.0000000000005857","volume":"91","author":"C Tassorelli","year":"2018","unstructured":"Tassorelli C et al (2018) Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study, (in eng). Neurology 91(4):e364\u2013e373. https:\/\/doi.org\/10.1212\/wnl.0000000000005857","journal-title":"Neurology"},{"issue":"6","key":"5664_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1212\/wnl.55.6.754","volume":"55","author":"SD Silberstein","year":"2000","unstructured":"Silberstein SD (2000) Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology, (in eng). Neurology 55(6):754\u2013762. https:\/\/doi.org\/10.1212\/wnl.55.6.754","journal-title":"Neurology"},{"issue":"2","key":"5664_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","volume":"15","author":"JJY Ong","year":"2018","unstructured":"Ong JJY, De Felice M (2018) Migraine treatment: current acute medications and their potential mechanisms of action, (in eng). Neurotherapeutics 15(2):274\u2013290. https:\/\/doi.org\/10.1007\/s13311-017-0592-1","journal-title":"Neurotherapeutics"},{"issue":"5 Suppl 3","key":"5664_CR36","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S0317167100118943","volume":"40","author":"I Worthington","year":"2013","unstructured":"Worthington I et al (2013) Canadian Headache Society Guideline: acute drug therapy for migraine headache, (in eng). Can J Neurol Sci 40(5 Suppl 3):S1-s80","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"5664_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3122\/jabfm.2018.02.170188","volume":"31","author":"SM Allen","year":"2018","unstructured":"Allen SM, Mookadam F, Cha SS, Freeman JA, Starling AJ, Mookadam M (2018) Greater occipital nerve block for acute treatment of migraine headache: a large retrospective cohort study, (in eng). J Am Board Fam Med 31(2):211\u2013218. https:\/\/doi.org\/10.3122\/jabfm.2018.02.170188","journal-title":"J Am Board Fam Med"},{"issue":"7","key":"5664_CR38","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1742-1241.2007.01400.x","volume":"61","author":"DS Ng-Mak","year":"2007","unstructured":"Ng-Mak DS, Hu XH, Chen Y, Ma L, Solomon G (2007) Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans, (in eng). Int J Clin Pract 61(7):1091\u20131111. https:\/\/doi.org\/10.1111\/j.1742-1241.2007.01400.x","journal-title":"Int J Clin Pract"},{"key":"5664_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s40064-016-2211-8","volume":"5","author":"F Antonaci","year":"2016","unstructured":"Antonaci F, Ghiotto N, Wu S, Pucci E, Costa A (2016) Recent advances in migraine therapy, (in eng). Springerplus 5:637. https:\/\/doi.org\/10.1186\/s40064-016-2211-8","journal-title":"Springerplus"},{"issue":"7659","key":"5664_CR40","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1136\/bmj.39559.675891.AD","volume":"336","author":"PJ Goadsby","year":"2008","unstructured":"Goadsby PJ, Goldberg J, Silberstein SD (2008) Migraine in pregnancy, (in eng). BMJ 336(7659):1502\u20131504. https:\/\/doi.org\/10.1136\/bmj.39559.675891.AD","journal-title":"BMJ"},{"issue":"6","key":"5664_CR41","first-page":"537","volume":"56","author":"S Duong","year":"2010","unstructured":"Duong S, Bozzo P, Nordeng H, Einarson A (2010) Safety of triptans for migraine headaches during pregnancy and breastfeeding, (in eng). Can Fam Physician 56(6):537\u2013539","journal-title":"Can Fam Physician"},{"key":"5664_CR42","unstructured":"FDA. 510(k) Clearances. US Food & Drug Administration. https:\/\/www.fda.gov\/medical-devices\/device-approvals-denials-and-clearances\/510k-clearances (accessed October 24th, 2020)"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05664-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T18:38:21Z","timestamp":1641235101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5664"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05664-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"assertion":[{"value":"9 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Ana Marissa Lagman-Bartolome reports advisory board honorarium fees from Allergan, Novartis, TEVA, Eli Lilly, Lundbeck, and Aralez, outside the submitted work.All the other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"PROSPERO registration number CRD42018094414.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registration"}}]}}